Protein specific to pancreatic beta cells in islets of langerhans and applications thereof
CA 2506331 C · Owner: Universite Joseph Fourier · Inventors: Favier, Alain; Seve, Michel
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention relates to protein ZnT-8 which is specifically expressed in the pancreatic beta cells in islets of Langerhans to a polynucleotide encoding said protein which is involved in the maturation and exocytosis of insulin and to the applications thereof, for example for sorting and studying beta cells and for screening medicine acting on diabetes and hyperinsulinism.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed November 18, 2003 and granted February 17, 2015. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended November 18, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by November 18, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.